.jpg?format=webp&width=780)
The article is a clinical consensus statement discussing the use of inotropic support in patients with advanced heart failure. The current guidelines support inotropes only for acute decompensated heart failure with organ malperfusion or shock, but the use of inotropes may be reasonable in other advanced heart failure patients without severe decompensation. The clinical evidence supporting inotropes in these situations is reviewed, including the use of traditional and novel drugs with inotropic effects and the importance of guideline-directed therapy during inotropic support. The article also covers home inotropic therapy and the management of ongoing inotropic support, including guidance for maintenance and weaning of chronic inotropic therapy support. Palliative care and end-of-life aspects are also discussed.
Like
Save
Share